Marksans Pharma Limiteds wholly owned subsidiary Relonchem Limited receives market authorization for the product Cyanocobalamin 50mg film coated tablets
Marksans Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release
November 6, 2023
Download PDF
Marksans Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month